Four-Year Survival After Trans-jugular Intrahepatic Porto-systemic Shunt for Veno-occlusive Disease Following Autologous Bone Marrow Transplantation

Severe hepatic veno-occlusive disease is still a potentially lethal complication after bone marrow transplantation. We here report the case of a patient who developed liver veno-occlusive disease with severe hemodynamic dysfunction and was successfully treated by means of a trans-jugular intrahepati...

Full description

Saved in:
Bibliographic Details
Published in:Leukemia & lymphoma 2004-07, Vol.45 (7), p.1485-1487
Main Authors: Annaloro, Claudio, Robbiolo, Livia, Pozzoli, Ermanno, Ibatici, Adalberto, Nicolini, Antonio, Salerno, Francesco, Deliliers, Giorgio Lambertenghi
Format: Article
Language:English
Subjects:
Adult
Bone marrow transplantation
Carmustine - adverse effects
Combined Modality Therapy
Cyclophosphamide - adverse effects
Etoposide - adverse effects
Hemodynamics
Hepatic Veno-Occlusive Disease - chemically induced
Hepatic Veno-Occlusive Disease - physiopathology
Hepatic Veno-Occlusive Disease - surgery
Humans
Jugular Veins
Lymphoma, Large-Cell, Anaplastic - therapy
Male
Peripheral Blood Stem Cell Transplantation
Portasystemic Shunt, Surgical
Remission Induction
Thrombophilia - etiology
Trans-jugular intrahepatic portosystemic shunt
Transplantation Conditioning - adverse effects
Transplantation, Autologous
Veno-occlusive liver disease
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c414t-861cae82214fcfa837d0ad7ef51fb8999f440db5c36725a99d50f85b226059923
cites cdi_FETCH-LOGICAL-c414t-861cae82214fcfa837d0ad7ef51fb8999f440db5c36725a99d50f85b226059923
container_end_page 1487
container_issue 7
container_start_page 1485
container_title Leukemia & lymphoma
container_volume 45
creator Annaloro, Claudio
Robbiolo, Livia
Pozzoli, Ermanno
Ibatici, Adalberto
Nicolini, Antonio
Salerno, Francesco
Deliliers, Giorgio Lambertenghi
description Severe hepatic veno-occlusive disease is still a potentially lethal complication after bone marrow transplantation. We here report the case of a patient who developed liver veno-occlusive disease with severe hemodynamic dysfunction and was successfully treated by means of a trans-jugular intrahepatic portosystemic shunt. After three years, he is still disease-free with a functioning shunt and a normal laboratory liver profile. A trans-jugular intrahepatic portosystemic shunt is a treatment option that has been used in very few patients affected by hepatic veno-occlusive disease; its indications and timing remain to be established.
doi_str_mv 10.1080/10428190410001663626
format article
fullrecord <record><control><sourceid>pubmed_infor</sourceid><recordid>TN_cdi_informahealthcare_journals_10_1080_10428190410001663626</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15359654</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-861cae82214fcfa837d0ad7ef51fb8999f440db5c36725a99d50f85b226059923</originalsourceid><addsrcrecordid>eNqFkdGKEzEUhoMo7rr6BiJ5gWiSyUwnN0rdtbqworCr4NVwmknaKWlSTpKWvocPbJYuiCB6lRPy___J-Q4hLwV_LXjP3wiuZC80V4JzLrqu6WT3iJwLLjWTijeP72slWdWoM_IspU3VtbqTT8mZaJtateqc_FzEguyHBaS3BffTHjydu2yR3iGExDZlVXx9vA4ZYW13kCdDv0bMkaVjynZbr7frEjJ1Eel3GyKLxviSpr2lV1OykCxdRO_jYQorOi85-riKJdH3MVj6GRDj4dRr5yHkmh_Dc_LEgU_2xcN5Qb4tPtxdfmI3Xz5eX85vmFFCZdZ3woDtpRTKGQd9Mxs5jDPrWuGWvdbaKcXHZWuabiZb0HpsuevbpZRdBaFlc0HUKddgTAmtG3Y4bQGPg-DDPeThb5Cr7dXJtivLrR1_mx6oVsG7k2AKlcoWDhH9OGQ4-oiujmqmNDT_afH2j4S1BZ_XBtAOm7qwUKn8-4-_AAlQoT8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Four-Year Survival After Trans-jugular Intrahepatic Porto-systemic Shunt for Veno-occlusive Disease Following Autologous Bone Marrow Transplantation</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Annaloro, Claudio ; Robbiolo, Livia ; Pozzoli, Ermanno ; Ibatici, Adalberto ; Nicolini, Antonio ; Salerno, Francesco ; Deliliers, Giorgio Lambertenghi</creator><creatorcontrib>Annaloro, Claudio ; Robbiolo, Livia ; Pozzoli, Ermanno ; Ibatici, Adalberto ; Nicolini, Antonio ; Salerno, Francesco ; Deliliers, Giorgio Lambertenghi</creatorcontrib><description>Severe hepatic veno-occlusive disease is still a potentially lethal complication after bone marrow transplantation. We here report the case of a patient who developed liver veno-occlusive disease with severe hemodynamic dysfunction and was successfully treated by means of a trans-jugular intrahepatic portosystemic shunt. After three years, he is still disease-free with a functioning shunt and a normal laboratory liver profile. A trans-jugular intrahepatic portosystemic shunt is a treatment option that has been used in very few patients affected by hepatic veno-occlusive disease; its indications and timing remain to be established.</description><identifier>ISSN: 1042-8194</identifier><identifier>EISSN: 1029-2403</identifier><identifier>DOI: 10.1080/10428190410001663626</identifier><identifier>PMID: 15359654</identifier><language>eng</language><publisher>United States: Informa UK Ltd</publisher><subject>Adult ; Bone marrow transplantation ; Carmustine - adverse effects ; Combined Modality Therapy ; Cyclophosphamide - adverse effects ; Etoposide - adverse effects ; Hemodynamics ; Hepatic Veno-Occlusive Disease - chemically induced ; Hepatic Veno-Occlusive Disease - physiopathology ; Hepatic Veno-Occlusive Disease - surgery ; Humans ; Jugular Veins ; Lymphoma, Large-Cell, Anaplastic - therapy ; Male ; Peripheral Blood Stem Cell Transplantation ; Portasystemic Shunt, Surgical ; Remission Induction ; Thrombophilia - etiology ; Trans-jugular intrahepatic portosystemic shunt ; Transplantation Conditioning - adverse effects ; Transplantation, Autologous ; Veno-occlusive liver disease</subject><ispartof>Leukemia &amp; lymphoma, 2004-07, Vol.45 (7), p.1485-1487</ispartof><rights>2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-861cae82214fcfa837d0ad7ef51fb8999f440db5c36725a99d50f85b226059923</citedby><cites>FETCH-LOGICAL-c414t-861cae82214fcfa837d0ad7ef51fb8999f440db5c36725a99d50f85b226059923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15359654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Annaloro, Claudio</creatorcontrib><creatorcontrib>Robbiolo, Livia</creatorcontrib><creatorcontrib>Pozzoli, Ermanno</creatorcontrib><creatorcontrib>Ibatici, Adalberto</creatorcontrib><creatorcontrib>Nicolini, Antonio</creatorcontrib><creatorcontrib>Salerno, Francesco</creatorcontrib><creatorcontrib>Deliliers, Giorgio Lambertenghi</creatorcontrib><title>Four-Year Survival After Trans-jugular Intrahepatic Porto-systemic Shunt for Veno-occlusive Disease Following Autologous Bone Marrow Transplantation</title><title>Leukemia &amp; lymphoma</title><addtitle>Leuk Lymphoma</addtitle><description>Severe hepatic veno-occlusive disease is still a potentially lethal complication after bone marrow transplantation. We here report the case of a patient who developed liver veno-occlusive disease with severe hemodynamic dysfunction and was successfully treated by means of a trans-jugular intrahepatic portosystemic shunt. After three years, he is still disease-free with a functioning shunt and a normal laboratory liver profile. A trans-jugular intrahepatic portosystemic shunt is a treatment option that has been used in very few patients affected by hepatic veno-occlusive disease; its indications and timing remain to be established.</description><subject>Adult</subject><subject>Bone marrow transplantation</subject><subject>Carmustine - adverse effects</subject><subject>Combined Modality Therapy</subject><subject>Cyclophosphamide - adverse effects</subject><subject>Etoposide - adverse effects</subject><subject>Hemodynamics</subject><subject>Hepatic Veno-Occlusive Disease - chemically induced</subject><subject>Hepatic Veno-Occlusive Disease - physiopathology</subject><subject>Hepatic Veno-Occlusive Disease - surgery</subject><subject>Humans</subject><subject>Jugular Veins</subject><subject>Lymphoma, Large-Cell, Anaplastic - therapy</subject><subject>Male</subject><subject>Peripheral Blood Stem Cell Transplantation</subject><subject>Portasystemic Shunt, Surgical</subject><subject>Remission Induction</subject><subject>Thrombophilia - etiology</subject><subject>Trans-jugular intrahepatic portosystemic shunt</subject><subject>Transplantation Conditioning - adverse effects</subject><subject>Transplantation, Autologous</subject><subject>Veno-occlusive liver disease</subject><issn>1042-8194</issn><issn>1029-2403</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqFkdGKEzEUhoMo7rr6BiJ5gWiSyUwnN0rdtbqworCr4NVwmknaKWlSTpKWvocPbJYuiCB6lRPy___J-Q4hLwV_LXjP3wiuZC80V4JzLrqu6WT3iJwLLjWTijeP72slWdWoM_IspU3VtbqTT8mZaJtateqc_FzEguyHBaS3BffTHjydu2yR3iGExDZlVXx9vA4ZYW13kCdDv0bMkaVjynZbr7frEjJ1Eel3GyKLxviSpr2lV1OykCxdRO_jYQorOi85-riKJdH3MVj6GRDj4dRr5yHkmh_Dc_LEgU_2xcN5Qb4tPtxdfmI3Xz5eX85vmFFCZdZ3woDtpRTKGQd9Mxs5jDPrWuGWvdbaKcXHZWuabiZb0HpsuevbpZRdBaFlc0HUKddgTAmtG3Y4bQGPg-DDPeThb5Cr7dXJtivLrR1_mx6oVsG7k2AKlcoWDhH9OGQ4-oiujmqmNDT_afH2j4S1BZ_XBtAOm7qwUKn8-4-_AAlQoT8</recordid><startdate>200407</startdate><enddate>200407</enddate><creator>Annaloro, Claudio</creator><creator>Robbiolo, Livia</creator><creator>Pozzoli, Ermanno</creator><creator>Ibatici, Adalberto</creator><creator>Nicolini, Antonio</creator><creator>Salerno, Francesco</creator><creator>Deliliers, Giorgio Lambertenghi</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200407</creationdate><title>Four-Year Survival After Trans-jugular Intrahepatic Porto-systemic Shunt for Veno-occlusive Disease Following Autologous Bone Marrow Transplantation</title><author>Annaloro, Claudio ; Robbiolo, Livia ; Pozzoli, Ermanno ; Ibatici, Adalberto ; Nicolini, Antonio ; Salerno, Francesco ; Deliliers, Giorgio Lambertenghi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-861cae82214fcfa837d0ad7ef51fb8999f440db5c36725a99d50f85b226059923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Bone marrow transplantation</topic><topic>Carmustine - adverse effects</topic><topic>Combined Modality Therapy</topic><topic>Cyclophosphamide - adverse effects</topic><topic>Etoposide - adverse effects</topic><topic>Hemodynamics</topic><topic>Hepatic Veno-Occlusive Disease - chemically induced</topic><topic>Hepatic Veno-Occlusive Disease - physiopathology</topic><topic>Hepatic Veno-Occlusive Disease - surgery</topic><topic>Humans</topic><topic>Jugular Veins</topic><topic>Lymphoma, Large-Cell, Anaplastic - therapy</topic><topic>Male</topic><topic>Peripheral Blood Stem Cell Transplantation</topic><topic>Portasystemic Shunt, Surgical</topic><topic>Remission Induction</topic><topic>Thrombophilia - etiology</topic><topic>Trans-jugular intrahepatic portosystemic shunt</topic><topic>Transplantation Conditioning - adverse effects</topic><topic>Transplantation, Autologous</topic><topic>Veno-occlusive liver disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Annaloro, Claudio</creatorcontrib><creatorcontrib>Robbiolo, Livia</creatorcontrib><creatorcontrib>Pozzoli, Ermanno</creatorcontrib><creatorcontrib>Ibatici, Adalberto</creatorcontrib><creatorcontrib>Nicolini, Antonio</creatorcontrib><creatorcontrib>Salerno, Francesco</creatorcontrib><creatorcontrib>Deliliers, Giorgio Lambertenghi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Leukemia &amp; lymphoma</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Annaloro, Claudio</au><au>Robbiolo, Livia</au><au>Pozzoli, Ermanno</au><au>Ibatici, Adalberto</au><au>Nicolini, Antonio</au><au>Salerno, Francesco</au><au>Deliliers, Giorgio Lambertenghi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Four-Year Survival After Trans-jugular Intrahepatic Porto-systemic Shunt for Veno-occlusive Disease Following Autologous Bone Marrow Transplantation</atitle><jtitle>Leukemia &amp; lymphoma</jtitle><addtitle>Leuk Lymphoma</addtitle><date>2004-07</date><risdate>2004</risdate><volume>45</volume><issue>7</issue><spage>1485</spage><epage>1487</epage><pages>1485-1487</pages><issn>1042-8194</issn><eissn>1029-2403</eissn><abstract>Severe hepatic veno-occlusive disease is still a potentially lethal complication after bone marrow transplantation. We here report the case of a patient who developed liver veno-occlusive disease with severe hemodynamic dysfunction and was successfully treated by means of a trans-jugular intrahepatic portosystemic shunt. After three years, he is still disease-free with a functioning shunt and a normal laboratory liver profile. A trans-jugular intrahepatic portosystemic shunt is a treatment option that has been used in very few patients affected by hepatic veno-occlusive disease; its indications and timing remain to be established.</abstract><cop>United States</cop><pub>Informa UK Ltd</pub><pmid>15359654</pmid><doi>10.1080/10428190410001663626</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1042-8194
ispartof Leukemia & lymphoma, 2004-07, Vol.45 (7), p.1485-1487
issn 1042-8194
1029-2403
language eng
recordid cdi_informahealthcare_journals_10_1080_10428190410001663626
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Adult
Bone marrow transplantation
Carmustine - adverse effects
Combined Modality Therapy
Cyclophosphamide - adverse effects
Etoposide - adverse effects
Hemodynamics
Hepatic Veno-Occlusive Disease - chemically induced
Hepatic Veno-Occlusive Disease - physiopathology
Hepatic Veno-Occlusive Disease - surgery
Humans
Jugular Veins
Lymphoma, Large-Cell, Anaplastic - therapy
Male
Peripheral Blood Stem Cell Transplantation
Portasystemic Shunt, Surgical
Remission Induction
Thrombophilia - etiology
Trans-jugular intrahepatic portosystemic shunt
Transplantation Conditioning - adverse effects
Transplantation, Autologous
Veno-occlusive liver disease
title Four-Year Survival After Trans-jugular Intrahepatic Porto-systemic Shunt for Veno-occlusive Disease Following Autologous Bone Marrow Transplantation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A55%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Four-Year%20Survival%20After%20Trans-jugular%20Intrahepatic%20Porto-systemic%20Shunt%20for%20Veno-occlusive%20Disease%20Following%20Autologous%20Bone%20Marrow%20Transplantation&rft.jtitle=Leukemia%20&%20lymphoma&rft.au=Annaloro,%20Claudio&rft.date=2004-07&rft.volume=45&rft.issue=7&rft.spage=1485&rft.epage=1487&rft.pages=1485-1487&rft.issn=1042-8194&rft.eissn=1029-2403&rft_id=info:doi/10.1080/10428190410001663626&rft_dat=%3Cpubmed_infor%3E15359654%3C/pubmed_infor%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c414t-861cae82214fcfa837d0ad7ef51fb8999f440db5c36725a99d50f85b226059923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/15359654&rfr_iscdi=true